Albert Friesen

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

Sensible Medical Innovations Ltd. develops non-invasive devices for monitoring congestive heart failures. The firm also developed an imaging method for internal organs based on information technology. The company was founded by Nadav Mizrahi, Amir Soroka, Dan Rappaport, Amir Ronen and Shlomi Bergida in 2007 and is headquartered in Netanya, Israel.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada.

CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba.

Sensible Medical Innovations Ltd. develops non-invasive devices for monitoring congestive heart failures. The firm also developed an imaging method for internal organs based on information technology. The company was founded by Nadav Mizrahi, Amir Soroka, Dan Rappaport, Amir Ronen and Shlomi Bergida in 2007 and is headquartered in Netanya, Israel.